AACE published its first updated guideline on the pharmacologic management of adults with dyslipidemia since 2017, incorporating new recommendations for recently approved medications. Developed using the GRADE methodology, the guideline prioritizes patient-related factors, including social and economic considerations. AACE members Shailendra B. Patel, BM, ChB, DPhil, and Kathleen L. Wyne, MD, PhD, emphasize the need for more research on LDL cholesterol targets, diabetes, and metabolic liver disease. Read the full article on Healio for expert insights and key recommendations.